Terapias Basadas en Citoquinas
Universitat de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat de Barcelona (7)
2023
-
Identification and experimental validation of druggable epigenetic targets in hepatoblastoma
Journal of Hepatology, Vol. 79, Núm. 4, pp. 989-1005
2021
-
Anti-TGFβ (Transforming Growth Factor β) Therapy With Betaglycan-Derived P144 Peptide Gene Delivery Prevents the Formation of Aortic Aneurysm in a Mouse Model of Marfan Syndrome
Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 41, Núm. 9, pp. E440-E452
-
CD137 Costimulation Counteracts TGFβ Inhibition of NK-cell Antitumor Function
Cancer Immunology Research, Vol. 9, Núm. 12, pp. 1476-1490
2020
-
Production and use of adeno-associated virus vectors as tools for cancer immunotherapy
Methods in Enzymology (Academic Press Inc.), pp. 185-203
2019
-
Treatment of experimental autoimmune encephalomyelitis by sustained delivery of low-dose IFN-a
Journal of Immunology, Vol. 203, Núm. 3, pp. 696-704
2017
-
Exploiting scavenger receptors in cancer immunotherapy: Lessons from CD5 and SR-B1
European Journal of Immunology, Vol. 47, Núm. 7, pp. 1108-1118
-
Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: Development of an FGF19-based chimeric molecule to promote fatty liver regeneration
Gut, Vol. 66, Núm. 10, pp. 1818-1828